Usefulness of Plasma YKL-40 in Management of Community-Acquired Pneumonia Severity in Patients

YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages

(2014) S. Letuve et al.   JOURNAL OF IMMUNOLOGY

Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease

(2012) Hak-Ryul Kim et al.   CYTOKINE

Chitinase 3-like 1 gene-329G/A polymorphism, plasma concentration and risk of coronary heart disease in a Chinese population

(2012) Fangyi Xie et al.   GENE

Significant Association of Elevated Concentration of Plasma YKL-40 with Disease Severity in Patients With Pelvic Inflammatory Disease

(2012) Shu-Hsin Lee et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients

(2012) Jun Ho Lee et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients

(2012) Hyun Young Park et al.   PLoS One

Plasma YKL-40 levels in healthy subjects from the general population

(2011) Stig E. Bojesen et al.   CLINICA CHIMICA ACTA

Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia

(2011) Yuan-Ti Lee et al.   CLINICA CHIMICA ACTA

Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population

(2011) Jian Lei Zheng et al.   CYTOKINE

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

(2009) Camilla N Rathcke et al.   Cardiovascular Diabetology

Plasma YKL-40: a potential new cancer biomarker?

(2009) Julia S Johansen et al.   Future Oncology

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

(2008) C. N. Rathcke et al.   DIABETES CARE

Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung Function

(2008) Carole Ober et al.   NEW ENGLAND JOURNAL OF MEDICINE